Ireland

‘Optimising therapeutic strategies to address complex clinical challenges in CLL and FL’ is a evening medical education meeting focusing on Chronic Lymphocytic Leukaemia (CLL) and Follicular Lymphoma (FL). The meeting will bring together a notable faculty of oncology experts from across the Ireland who will preview the latest advances in research, consider the likely impact on the clinic of tomorrow, and discuss and debate the pertinent issues which are affecting the professional community.

Chair

Elisabeth Vandenberghe
Clinical Professor, Haematology
The University of Dublin

Costs
The meeting costs are underwritten by Gilead Sciences Ltd. and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.

ONC/UK/18-02/NMAR/1080g(1)
Date of preparation: August 2018

This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.